Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1000 of 3546 entries
View as:

Repeat Dose Study in Male Healthy Volunteer Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00615576 Org: User:
Start: 03/26/08 End: 07/24/08 Due: 07/24/09

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT01323946 Org: User:
Start: 04/18/11 End: 11/02/12 Due: 11/02/13

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT00435695 Org: User:
Start: 11/30/06 End: 12/31/07 Due: 12/31/08

Comparison of Pharmacokinetic Profiles of Two Nicotine Gum Formulations

Phase: N/A Priority: Normal
NCT ID: NCT01847443 Org: User:
Start: 05/31/13 End: 06/30/13 Due: 06/30/14

QTc Study of Rosi XR in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00884533 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response

Phase: N/A Priority: Normal
NCT ID: NCT01128569 Org: User:
Start: 01/31/10 End: 10/31/10 Due: 10/31/11

Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01221987 Org: User:
Start: 10/31/09 End: 09/30/10 Due: 09/30/11

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Phase: N/A Priority: Normal
NCT ID: NCT00291967 Org: User:
Start: 11/30/02 End: - Due: -

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02979639 Org: User:
Start: 01/16/17 End: 05/24/18 Due: 05/24/19

A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Phase: N/A Priority: Normal
NCT ID: NCT02570126 Org: User:
Start: 11/13/15 End: 10/25/16 Due: 10/25/17

A Study to Evaluate the Cooling Sensation and Consumer Liking of a Skin Disinfectant Spray

Phase: N/A Priority: Normal
NCT ID: NCT02106403 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Phase: N/A Priority: Normal
NCT ID: NCT01000324 Org: User:
Start: 11/06/09 End: 07/25/14 Due: 07/25/15

Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

Phase: N/A Priority: Normal
NCT ID: NCT00688272 Org: User:
Start: 06/02/08 End: 09/25/08 Due: 09/25/09

Alcohol Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT01181908 Org: User:
Start: 11/11/09 End: 12/30/09 Due: 12/30/10

Ability of Four Toothpastes to Remove Plaque

Phase: N/A Priority: Normal
NCT ID: NCT03285984 Org: User:
Start: 03/27/12 End: 05/08/12 Due: 05/08/13

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS)

Phase: N/A Priority: Normal
NCT ID: NCT03239600 Org: User:
Start: 09/19/17 End: 10/12/17 Due: 10/12/18

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00622388 Org: User:
Start: 12/31/07 End: 08/31/14 Due: 08/31/15

Study of Mepolizumab Safety Syringe in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT03021304 Org: User:
Start: 02/01/17 End: 08/08/17 Due: 08/08/18

Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557

Phase: N/A Priority: Normal
NCT ID: NCT01462617 Org: User:
Start: 07/24/11 End: 03/26/12 Due: 03/26/13

Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00709618 Org: User:
Start: 06/30/08 End: 05/31/12 Due: 05/31/13

Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01090440 Org: User:
Start: 09/01/09 End: 10/09/09 Due: 10/09/10

Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over

Phase: N/A Priority: Normal
NCT ID: NCT00532298 Org: User:
Start: 09/20/07 End: 11/02/07 Due: 11/02/08

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

Phase: N/A Priority: Normal
NCT ID: NCT01122849 Org: User:
Start: 10/01/09 End: 02/01/10 Due: 02/01/11

A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01853878 Org: User:
Start: 06/12/13 End: 08/24/16 Due: 08/24/17

Study to Assess the Effect of Food on the Concentration of GW273225 in the Body of Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00501865 Org: User:
Start: 08/06/07 End: 10/11/07 Due: 10/11/08